GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » Deferred Tax

Nanalysis Scientific (TSXV:NSCI) Deferred Tax : C$0.98 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Nanalysis Scientific's change in deferred tax for the three months ended in Sep. 2024 was C$0.03 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.98 Mil.


Nanalysis Scientific Deferred Tax Historical Data

The historical data trend for Nanalysis Scientific's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific Deferred Tax Chart

Nanalysis Scientific Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial 0.26 -0.30 - -0.73 -0.02

Nanalysis Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 0.99 -0.02 -0.01 0.03

Nanalysis Scientific Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.98 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanalysis Scientific Deferred Tax Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanalysis Scientific Business Description

Traded in Other Exchanges
Address
Bay 105, 90 Freeport Blvd. NE, Calgary, AB, CAN, T3J 5J9
Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. The Company's activities are carried out through three operating segments, within which are two reportable segments which include Scientific Equipment which includes sales of proprietary and third-party products and Security Services involves maintenance and installation of security equipment. Geographic segments of the group are the U.S., Europe, Canada, Asia, and Other regions.
Executives
Sean Edward Krakiwsky Director, Senior Officer
Guido Cloetens Director
Michal Okoniewski Director
Werner Gartner Director
Martin Andrew Burian Director
Luke Caplette Senior Officer
Julien Muller Senior Officer
Garett Leskowitz Senior Officer
Mohamed Abousalem Director

Nanalysis Scientific Headlines

No Headlines